Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-30

Clinical Trial Results: Study of SDX in Patients With Idiopathic Hypersomnia (IH) [Phase 2]

View source ↗

Summary

Phase 2 trial results for SDX in idiopathic hypersomnia have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SDX

Snippet

Sponsor: Zevra Therapeutics | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: COMPLETED | Results posted: 2026-06-30